Molecular Quality Controls Market is estimated to increase at a Compounded Annual Growth Rate of 7.7% CAGR over the forecast period from 2024 to 2030
The Molecular Quality Controls Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Independent Controls, Instrument-Specific Controls), By Analyte Type (Single, Multi), By Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Others), By End-User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others).
An Introduction to Molecular Quality Controls Market in 2024
Molecular quality controls are essential materials used to monitor and ensure the accuracy, precision, and reliability of molecular diagnostic tests, including nucleic acid amplification assays, PCR-based tests, and next-generation sequencing (NGS) assays. In 2024, the market for molecular quality controls continues to expand, driven by the increasing adoption of molecular testing in clinical laboratories, infectious disease surveillance, and precision medicine initiatives. Molecular quality controls mimic patient specimens and contain known quantities of target analytes or genetic material, allowing laboratories to assess the performance of their testing processes, detect assay variability, and verify test accuracy across different platforms and reagent lots. With the growing demand for high-quality molecular diagnostics and the need for standardized testing protocols, molecular quality controls play a critical role in ensuring the reliability and comparability of test results, supporting clinical decision-making and patient care. As regulatory requirements for laboratory accreditation and proficiency testing become more stringent, the market for molecular quality controls is expected to witness continued growth, driving investments in quality assurance programs, reference materials, and proficiency testing schemes. Moreover, advancements in molecular assay design, automation, and digitalization create new opportunities for molecular quality controls to enhance assay performance, reduce turnaround times, and improve laboratory efficiency, ultimately contributing to better patient outcomes and public health.
Market Trend: Increasing Adoption of Molecular Testing Assays
A prominent trend in the molecular quality controls market is the increasing adoption of molecular testing assays across various medical disciplines. Molecular diagnostics has revolutionized the detection and management of diseases by offering highly sensitive and specific tests for infectious diseases, genetic disorders, and oncology. As the demand for molecular testing continues to grow, driven by factors such as advancements in technology, rising prevalence of infectious diseases, and the shift towards personalized medicine, the need for reliable and accurate quality control materials becomes paramount. Laboratories and diagnostic manufacturers are increasingly relying on molecular quality controls to ensure the accuracy and reliability of their test results, driving market growth and innovation in the molecular quality controls sector.
Market Driver: Regulatory Standards and Accreditation Requirements
A key driver fueling the demand for molecular quality controls is the stringent regulatory standards and accreditation requirements governing clinical laboratories and diagnostic testing facilities. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the International Organization for Standardization (ISO), have established guidelines and requirements for quality assurance and quality control in molecular diagnostics. Additionally, accreditation organizations, such as the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA), mandate the use of quality control materials to ensure the accuracy and reliability of test results. Laboratories and diagnostic manufacturers must comply with these regulatory standards and accreditation requirements to maintain accreditation, ensure patient safety, and mitigate legal and financial risks. As a result, the demand for high-quality molecular quality control materials that meet regulatory standards and accreditation requirements is expected to increase, driving market growth and investment in the molecular quality controls market.
Market Opportunity: Development of Customized and Multiplexed Quality Controls
A significant opportunity for the molecular quality controls market lies in the development of customized and multiplexed quality control materials tailored to specific molecular testing assays and platforms. Molecular diagnostics assays vary widely in their target analytes, methodologies, and performance characteristics, requiring customized quality control materials that mimic patient samples and cover the full range of assay parameters. Additionally, with the increasing adoption of multiplexed testing platforms capable of simultaneously detecting multiple analytes, there is a growing need for multiplexed quality controls that enable comprehensive performance assessment and validation. By developing customizable and multiplexed quality control materials, manufacturers can address the diverse needs of laboratories and diagnostic facilities, streamline quality assurance processes, and improve assay performance and accuracy. Collaborating with assay developers, diagnostic manufacturers, and regulatory agencies to design and validate customized quality control materials presents opportunities for innovation and growth in the molecular quality controls market. By offering tailored solutions that meet the evolving needs of the molecular diagnostics industry, market players can position themselves as trusted partners in ensuring the reliability and accuracy of molecular testing assays, driving market competitiveness and success.
Molecular Quality Controls Market Share Analysis: Instrument-Specific Controls for Polymerase Chain Reaction (PCR) in Diagnostic Laboratories
is the fastest growing segment over the forecast period to 2030 Among the segments listed, instrument-specific controls for polymerase chain reaction (PCR) in diagnostic laboratories are experiencing rapid growth in the molecular quality controls market. This growth is primarily driven by the increasing demand for accurate and reliable quality control materials tailored to specific PCR instruments and assays used in clinical diagnostic testing. Instrument-specific controls ensure the accuracy and precision of PCR-based tests by validating the performance of PCR instruments, reagents, and assay protocols. They help diagnostic laboratories comply with regulatory requirements, such as Clinical Laboratory Improvement Amendments (CLIA) and ISO 15189, by ensuring the quality and reliability of test results. Additionally, with the growing adoption of PCR technology for infectious disease diagnostics, oncology testing, and genetic testing, there is a heightened need for instrument-specific controls to monitor and maintain assay performance and accuracy. As diagnostic laboratories strive to enhance the quality and reliability of molecular diagnostic testing, the demand for instrument-specific controls for PCR instruments is expected to continue growing rapidly. With ongoing advancements in molecular testing technologies and increasing regulatory scrutiny on laboratory quality management, instrument-specific controls play a crucial role in ensuring the integrity and accuracy of diagnostic testing in clinical laboratories.
Molecular Quality Controls Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories Inc, Anchor Molecular Inc, Bio-Rad Laboratories Inc, Bio-Techne Corp, Danaher Corp, F. Hoffmann-La Roche Ltd, Fortress Diagnostics Ltd, Grifols S.A., Helena Laboratories Corp, LGC Ltd, Maine Molecular Quality Controls Inc, Microbiologics Inc, Microbix Biosystems Inc, Molbio Diagnostics Pvt. Ltd, Ortho Clinical Diagnostics Inc, Qnostics Ltd, Quidel Corp, Randox Laboratories Ltd, Seegene Inc, SERO AS, SpeeDx Pty. Ltd, Steck LLC, Sun Diagnostics LLC, Thermo Fisher Scientific Inc, Vircell S.L., ZeptoMetrix Corp
Molecular Quality Controls Market Segmentation
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Molecular Quality Controls Market Companies
Abbott Laboratories Inc
Anchor Molecular Inc
Bio-Rad Laboratories Inc
Bio-Techne Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Fortress Diagnostics Ltd
Grifols S.A.
Helena Laboratories Corp
LGC Ltd
Maine Molecular Quality Controls Inc
Microbiologics Inc
Microbix Biosystems Inc
Molbio Diagnostics Pvt. Ltd
Ortho Clinical Diagnostics Inc
Qnostics Ltd
Quidel Corp
Randox Laboratories Ltd
Seegene Inc
SERO AS
SpeeDx Pty. Ltd
Steck LLC
Sun Diagnostics LLC
Thermo Fisher Scientific Inc
Vircell S.L.
ZeptoMetrix Corp
Reasons to Buy the Molecular Quality Controls Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Molecular Quality Controls Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Molecular Quality Controls Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Molecular Quality Controls Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Molecular Quality Controls Market Size Outlook, $ Million, 2021 to 2030
3.2 Molecular Quality Controls Market Outlook by Type, $ Million, 2021 to 2030
3.3 Molecular Quality Controls Market Outlook by Product, $ Million, 2021 to 2030
3.4 Molecular Quality Controls Market Outlook by Application, $ Million, 2021 to 2030
3.5 Molecular Quality Controls Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Molecular Quality Controls Industry
4.2 Key Market Trends in Molecular Quality Controls Industry
4.3 Potential Opportunities in Molecular Quality Controls Industry
4.4 Key Challenges in Molecular Quality Controls Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Molecular Quality Controls Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Molecular Quality Controls Market Outlook by Segments
7.1 Molecular Quality Controls Market Outlook by Segments, $ Million, 2021- 2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
8 North America Molecular Quality Controls Market Analysis and Outlook To 2030
8.1 Introduction to North America Molecular Quality Controls Markets in 2024
8.2 North America Molecular Quality Controls Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Molecular Quality Controls Market size Outlook by Segments, 2021-2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
9 Europe Molecular Quality Controls Market Analysis and Outlook To 2030
9.1 Introduction to Europe Molecular Quality Controls Markets in 2024
9.2 Europe Molecular Quality Controls Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Molecular Quality Controls Market Size Outlook by Segments, 2021-2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
10 Asia Pacific Molecular Quality Controls Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Molecular Quality Controls Markets in 2024
10.2 Asia Pacific Molecular Quality Controls Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Molecular Quality Controls Market size Outlook by Segments, 2021-2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
11 South America Molecular Quality Controls Market Analysis and Outlook To 2030
11.1 Introduction to South America Molecular Quality Controls Markets in 2024
11.2 South America Molecular Quality Controls Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Molecular Quality Controls Market size Outlook by Segments, 2021-2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
12 Middle East and Africa Molecular Quality Controls Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Molecular Quality Controls Markets in 2024
12.2 Middle East and Africa Molecular Quality Controls Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Molecular Quality Controls Market size Outlook by Segments, 2021-2030
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories Inc
Anchor Molecular Inc
Bio-Rad Laboratories Inc
Bio-Techne Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Fortress Diagnostics Ltd
Grifols S.A.
Helena Laboratories Corp
LGC Ltd
Maine Molecular Quality Controls Inc
Microbiologics Inc
Microbix Biosystems Inc
Molbio Diagnostics Pvt. Ltd
Ortho Clinical Diagnostics Inc
Qnostics Ltd
Quidel Corp
Randox Laboratories Ltd
Seegene Inc
SERO AS
SpeeDx Pty. Ltd
Steck LLC
Sun Diagnostics LLC
Thermo Fisher Scientific Inc
Vircell S.L.
ZeptoMetrix Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Independent Controls
Instrument-Specific Controls
-Polymerase Chain Reaction
-DNA Sequencing & NGS
-Others
By Analyte Type
Single
Multi
By Application
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Others
By End-User
Diagnostic Laboratories
Hospitals
IVD Manufacturers & Contract Research Organizations
Academic & Research Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
